And repeated just as much as the fantasies continually mentioning the value of the Cytogenix IP, the company's alleged "science", its potential buyout prospects, its dubious partnerships and the misfortunes (and not fraud) of the firm's management. And the oft repeated siren song offered to the cheated shareholders of "hope".